Percutaneous vertebral body perforation is a new technique for treating painful vertebral compression fractures (VCFs). We prospectively evaluated this treatment in 45 consecutive patients with 63 VCFs treated at our hospital between September and December 2009. In all patients, long-term conservative treatment had failed to achieve pain relief, resulting in reduced changes in activities of daily living (ADL). We evaluated visual analogue scale (VAS) scores for pain before and after vertebral body perforation as well as in the chronic phase, changes in ADL, whether recipients would recommend this treatment, and complications. The mean VAS score improved from 6.9 ± 1.9 before surgery to 3.6 ± 2.9 immediately after surgery, and to 2.5 ± 2.1 at 3 months. ADL was improved in 27 patients, and walking became possible in 16 of 24 patients who had been unable to walk. Nearly two-thirds of patients would strongly recommend this treatment to others. The analgesic effect of vertebral body perforation was significantly lower in patients with than in those without vertebral pseudarthrosis before surgery. Only 1 patient suffered a new fracture during the 3-month period after surgery, but there were no perioperative complications. Vertebral body perforation for painful VCFs can achieve early improvement of ADL due to the analgesic effect in carefully selected patients and is a safe treatment with a low frequency of complications.
Introduction
Painful vertebral compression fractures (VCFs) refractory to conservative management have been treated by vertebroplasty with the infusion of bone cement. 6, [10] [11] [12] [13] 17, 18, 22) However, this treatment increases the risks of complications associated with intraoperative use of bone cement, postoperative new vertebral fractures, and other problems. 6, [10] [11] [12] [13] 17, 18, 22) Thus, vertebroplasty may not be the safest and most appropriate treatment procedure. Some anesthesiologists have emphasized that pain could be relieved by a procedure differing from conventional vertebroplasty, i.e., perforating and irrigating the vertebral body without the infusion of bone cement. 16, 24) Fracture pain is considered to be closely associated with increased intravertebral pressure. In fact, there are many reports documenting increased intravertebral pressure in compression-fractured vertebral bodies. [1] [2] [3] [4] [5] 7, 14, 15, 19) This study prospectively performed percutaneous vertebral body perforation in patients with VCF refractory to conservative treatment to evaluate the analgesic effect of this treatment, changes in activities of daily living (ADL), and the willingness of recipients to recommend the treatment.
Materials and Methods
This study included 45 consecutive patients with 63 affected vertebral bodies who visited our hospital due to osteoporotic VCF between September and December 2009. All patients had been managed conservatively for long periods by their own physicians but consulted our hospital due to poor relief of pain. Before surgery, all patients underwent frontal and lateral radiography and magnetic resonance (MR) imaging of the lumbar spine. Consent was obtained after sufficient information about the therapeutic procedure, including the intention not to infuse bone cement, had been provided. All patients fully understood the advantages and disadvantages of the procedures with and without injection of bone cement. Surgical indications were considered to be present when the patient had suffered painful osteoporotic compression fracture refractory to conservative treatment for at least 5 weeks, pain with a visual analogue scale (VAS) score of 5 or higher interfering with ADL, tapping pain at the spinal process of the fractured vertebral body, and lumbar spinal MR imaging findings of the affected vertebral body appearing as high signal intensity on short inversion time inversion recovery and low signal intensity on T 1 -weighted images. Patients with neurological symptoms were excluded from this study. All patients underwent percutaneous vertebral body perforation performed by the same author who had performed 280 vertebroplasties. Surgery was performed with the patient in the prone position under local anesthesia. Under C-arm guidance, 13 G biopsy needles were inserted via the bilateral translaminar routes into the anterior third of the vertebral body. The presence or absence of communication between the bilateral needle holes was checked, and blood or effusion in the vertebral body was aspirated. Contrast medium (Visipaque 270; Daiichi Sankyo Co., Ltd., Tokyo) was injected through the bilateral needles, and the position of the tip of each needle, communication with the vertebral vein, and the efflux pattern of the contrast medium were observed. Surgery was completed by withdrawing both needles. The patients were discharged on the same day after approximately 1 hour of bed rest.
Pain and ADL were evaluated before and immediately, 1 week, 1 month, and 3 months after surgery. Pain was evaluated using the VAS, with maximum 10 and 0 indicating no pain. ADL was evaluated using the following 5-point scale: grade 0, complete independence; grade 1, light assistance and able to walk with a stick; grade 2, moderate assistance and needing a wheelchair for movement; grade 3, major assistance and mostly bedridden; and grade 4, fully bedridden and needing total assistance. In addition, the willingness of recipients to recommend this treatment to other patients was investigated at 3 months after surgery by questionnaire, employing the following scale: level 5, very willing; level 4, moderately willing; level 3, uncertain; level 2, unwilling; and level 1, very unwilling.
The analgesic effect of the treatment after 3 months was evaluated in patients in whom a single vertebral body had been treated. The analgesic effect was expressed in each patient as the VAS score improvement rate [(preoperative score -postoperative score)/preoperative score ×100 (%)], and the treatment was considered as markedly (good responders) or insufficiently (poor responders) effective with VAS score improvement rate of 80% or higher versus 50% or lower, respectively. The evaluation items were age, cause of injury, time (days) from onset to surgery, presence or absence of vertebral dynamic mobility on preoperative radiograms, radiographic findings of the vertebral body, and presence or absence of communication between the bilateral needle holes. These factors were compared between the good and poor responders. Dynamic fracture mobility was determined preoperatively by comparing standing lateral radiographs with supine cross table lateral radiographs centered on the fractured vertebra. Dynamic mobility was present if the anterior, middle, or posterior index vertebral height, manually measured to the nearest millimeter with unaided vision, changed between the standing and supine radiographs.
Statistical analysis of postoperative pain relief and ADL improvements were performed with the Wilcoxon signed rank test. The relationships between these parameters and pain outcome were analyzed with Fisher's exact test. Differences were considered statistically significant at a p value º0.05. Table 1 shows the patient characteristics. The 45 patients, 10 males and 35 females with a mean age of (Fig. 1) , and the mean preoperative VAS score was 6.9 ± 1.9. The number of vertebral bodies treated was 1 in 30 patients, 2 in 12, and 3 in 3. Figure 2 shows the locations, which was most common in the thoracolumbar junction, and the distribution of lesions did not differ from that of most osteoporotic compression fractures. Figure 3 shows VAS score changes after surgery. The mean VAS score improved from 6.9 ± 1.9 to 3.6 ± 2.9 immediately after surgery (p º 0.001) and to 2.5 ± 2.1 after 3 months (Wilcoxon signed rank test, p º 0.001). Figure 4 shows changes in ADL. Improvements were observed in 26 of the 36 patients evaluated, and walking became possible in 16 of the 24 patients who had been unable to walk before surgery (Wilcoxon signed rank test, p º 0.004). Table 2 shows the relationships between the analgesic effect and various parameters. The presence of vertebral mobility before surgery was significantly Preoperative sagittal STIR MR image (E), lateral radiograph (F), and intraoperative lateral fluoroscopic view (G) obtained in a 66-year-old man with T12 compression fracture. The degree of vertebral body destruction was more than 90%, and severe kyphotic deformation was also noted. The biopsy needle barely penetrated the bone marrow and entered the cleft. The VAS score was 8 preoperatively and decreased to 5 immediately after surgery but remained at 6 after 3 months. There were no significant differences in age, cause of injury, time until treatment, or radiographic findings. Figure 6 shows the willingness of recipients to recommend the treatment to others 3 months after surgery. Of the 34 patients, 22 showed level 4 or 5 willingness, who would recommend the treatment to others. No perioperative adverse events, such as neurological abnormalities, intraoperative pulmonary embolism, and pneumothorax, occurred. One patient suffered a new fracture during the 3-month period after surgery and was treated a second time.
Results
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Discussion
Performing only vertebral body perforation without bone cement infusion reduced pain associated with VCFs by 48% immediately after surgery and by 62% in 3 months. ADL was also improved, as walking became possible immediately after surgery in 16 of 24 patients who had been unable to walk before surgery. Moreover, a questionnaire conducted 3 months after surgery showed that 65% of the patients would recommend this treatment to other sufferers with VCF. Of course, the placebo effects of the treatment cannot be ruled out. However, in addition to the analgesic effect being maintained for 3 months, the improvement of ADL and the willingness of patients to recommend the procedure clearly and directly indicate its efficacy. These observations Vertebral Perforation for VCFs are considered to confirm the effect of this treatment.
The potential analgesic mechanisms of vertebral body perforation include improved intramedullary blood flow, reduced intravertebral pressure, reduced stimulation of pain nerve fibers, elimination of pain-producing substances, and relief of periosteal pain, but the exact mechanism remains unknown. 16, 24) However, fracture pain is considered to be closely associated with increased intravertebral pressure. Bone marrow decompression was first applied for fracture pain mainly involving the long bones of the lower limbs, but also began to be applied to the treatment of VCFs. In fact, intravertebral pressures were measured in fractured and normal vertebral bodies on spinal processes in the 1970s, and demonstrated intravertebral pressure was significantly increased in fractured vertebral bodies. Moreover, intravertebral pressures vary among sites within the same vertebral body. 1, 2) Intravertebral pressures were measured in lumbar vertebrae of healthy volunteers and revealed these pressures to fluctuate depending on postures and positions, suggesting that movement-related pain due to VCFs is associated with changes in intravertebral pressures. 7) In our study, the proportion of good responders was significantly higher among patients without than among those with vertebral pseudarthrosis before surgery. We consider the cause of pain in a fractured vertebral body with pseudarthrosis, as in Case 2 shown in Fig. 5E -G, to possibly involve factors associated with vertebral mobility rather than increased intravertebral pressure. Although percutaneous vertebroplasty using bone cement for painful compression fractures has been indicated for patients with such vertebral mobility, vertebral body perforation has been regarded as unlikely to produce an analgesic effect. Previously, we reported that the analgesic effect of vertebral body perforation tends to be low in VCF patients with high percentage compression ratio. In that study, we did not examine the association between vertebral mobility and analgesic effect. 23) However, we speculate that the analgesic effect of vertebral body perforation was low because many patients with severe VCF had pseudarthrosis. Therefore, bone cement infusion may be needed to stabilize the vertebral bodies in patients with pain possibly caused by vertebral mobility. In such patients, careful consideration is necessary before the application of vertebral body perforation.
In the present study, there were no complications due to vertebral body perforation. One of the 45 patients suffered a new fracture during the 3-month period after surgery. This is an extremely low complication rate compared to the frequency of new fractures after conventional percutaneous vertebroplasty, which ranges from 41% to 67%. 8, 9, 20, 21) Furthermore, more than half of new fractures are considered to occur within 3 months postoperatively. 8, 9, 20, 21) The low frequency in this study was attributed to the avoidance of the most critical disadvantage of percutaneous vertebroplasty, i.e. the local firm fixation of the affected vertebral bodies with bone cement. This is the most important advantage of vertebral body perforation. Moreover, complications caused by bone cement, such as pulmonary embolism and leakage into the vertebral canal, can obviously be avoided. Although vertebral body perforation requires bilateral puncture to enhance the therapeutic effects, the puncture procedure itself does not increase the frequency of complications if the surgeon has sufficient experience in the use of Carm fluoroscopy or conventional percutaneous vertebroplasty.
We consider that vertebral body perforation without bone cement to be minimally invasive compared to conventional percutaneous vertebroplasty. Further accumulation of cases and long-term followup studies are necessary to confirm the efficacy of this treatment.
